We used harmonized RNA-sequencing data to compare DLL3 gene expression of high-risk neuroblastoma primary tumors (n = 126) to other pediatric and adult tumors (n = 1,189) as well as 7859 GTEx samples across 31 unique normal tissues. The gene discussed is DLL3; the disease is neuroblastoma.